Articles related to STIMULANTS

Discover how viloxazine ER could offer a new avenue for enhancing ADHD treatment efficacy in pediatric patients with inadequate response to stimulants.

The stimulant crisis is affecting ADHD treatment across the board; Dr. Greg Mattingly offers crucial insights into navigating this challenging landscape. Learn about alternative treatment options to better serve your patients.

Discover the latest advancements in ADHD therapies that promise greater efficacy and fewer side effects—options that can revolutionize personalized treatment plans.

The DEA and FDA are addressing the current prescription stimulant shortage, emphasizing both the importance of patient access and the need for responsible prescribing. Stay informed on the latest updates and consider alternative treatments where appropriate.

Uncover valuable strategies to guide your patients in mitigating glaucoma lifestyle-associated risk factors. Smoking significantly increases the risk of developing glaucoma. It results in episcleral vasoconstriction, impaired optic nerve perfusion, irregular blood flow, and higher vasospasms. Additionally, smoking boosts the eye’s oxidative load while reducing circulating antioxidants. Consequently, it amplifies glaucoma risks, especially in genetically susceptible individuals and heavy smokers. Actionably, recommend smoking-cessation apps and credible online resources to patients. Stress too has a considerable impact on glaucoma progression. Chronic stress triggers organ dysfunctions, including eye maladies, elevates intraocular pressure (IOP), and may cause vascular dysregulation, leading to partial hypoxia and hypoglycaemia. Additionally, blood pressure extremes, particularly nocturnal hypotension, heighten the risk of primary open-angle glaucoma. Therefore, endorse stress-reducing relaxation techniques and positive communication strategies to your patients. Turning to stimulants, caffeine and alcohol are noteworthy. Studies suggest that patients genetically predisposed to higher IOP levels may experience amplified effects post-caffeine consumption. Similarly, alcohol consumption correlates with increased IOP, thus posing as another modifiable glaucoma risk factor. In these cases, propose moderation in caffeine and alcohol consumption, advocating for gradual reductions and environmental changes to facilitate better habits. In conclusion, considering factors beyond IOP levels — smoking, stress, and stimulants […]

The United States is currently experiencing a shortage of Adderall, a medication used to treat attention deficit disorder (ADD)/attention deficit hyperactivity disorder (ADHD) and narcolepsy. The FDA, in frequent communication with manufacturers, has not provided a clear timeline for when the shortage will be resolved. The shortage is attributed to various factors. The demand for Adderall has increased significantly, with a 10% rise in prescriptions filled in 2021 compared to the previous year. The US Drug Enforcement Agency’s efforts to combat prescription drug misuse have also played a role in limiting production. Furthermore, the pandemic led to the emergence of telemedicine startups, making it easier for individuals to obtain Adderall prescriptions, sometimes inaccurately. While waiting for the supply to be restored, healthcare professionals can consider alternative therapies such as dexmethylphenidate, methylphenidate, and dextroamphetamine.